Evidence map›Paper›PMID 9636180›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1998

Transdominant genetic analysis of a growth control pathway.

G Caponigro, M R Abedi, A P Hurlburt, A Maxfield, W Judd, A Kamb

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1998. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.6field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 75 citations in OpenAlex.

  1. Article
  2. Lambda-display: a powerful tool for antigen discovery.Molecules (Basel, Switzerland) · 2011
    Review
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Isolation of peptide aptamers that inhibit intracellular processes.Proceedings of the National Academy of Sciences of the United States of America · 2000
    Article
  14. Article
  15. Production of cyclic peptides and proteins in vivo.Proceedings of the National Academy of Sciences of the United States of America · 1999
    Article
  16. "Mutagenesis" by peptide aptamers identifies genetic network members and pathway connections.Proceedings of the National Academy of Sciences of the United States of America · 1999
    Article
  17. Article
  18. Yeast and human genes that affect the Escherichia coli SOS response.Proceedings of the National Academy of Sciences of the United States of America · 1999
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

G CaponigroVentana Genetics, Inc., 421 Wakara Way, Salt Lake City, UT 84108, USA.
M R Abedi
A P Hurlburt
A Maxfield
W Judd
A Kamb
Ventana Research Corporation (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Genetic selections that use proteinaceous transdominant inhibitors encoded by DNA libraries to cause mutant phenocopies may facilitate genetic analysis in traditionally nongenetic organisms. We performed a selection for random short peptides and larger protein fragments (collectively termed "perturbagens") that inhibit the yeast pheromone response pathway. Peptide and protein fragment perturbagens that permit cell division in the presence of pheromone were recovered. Two perturbagens were derived from proteins required for pheromone response, and an additional two were derived from proteins that may negatively influence the pheromone response pathway. Furthermore, three known components of the pathway were identified as probable perturbagen targets based on physical interaction assays. Thus, by selection for transdominant inhibitors of pheromone response, multiple pathway components were identified either directly as gene fragments or indirectly as the likely targets of specific perturbagens. These results, combined with the results of previous work [Holzmayer, T. A., Pestov, D. G. & Roninson, I. B. (1992) Nucl. Acids. Res. 20, 711-717; Whiteway, M., Dignard, D. & Thomas, D. Y. (1992) Proc. Natl. Acad. Sci. USA 89, 9410-9414; and Gudkov, A. V., Kazarov, A. R., Thimmapaya, R., Axenovich, S. A., Mazo, I. A. & Roninson, I. B. (1994) Proc. Natl. Acad. Sci. USA 91, 3744-3748], suggest that transdominant genetic analysis of the type described here will be broadly applicable.

Indexed as

Models, GeneticCell CycleEpistasis, GeneticGenes, DominantGenetic TechniquesMating FactorPeptide FragmentsPeptide LibraryPeptidesPhenotypePheromonesSaccharomyces cerevisiaeMating FactorPeptide FragmentsPeptide LibraryPeptidesPheromones

Identifiers

PMID9636180
PMCPMC22667
OpenAlexW2075449564

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.